Banks will provide financing for the deal, and the buyout proposal is likely to be announced soon, they added. Hisamitsu confirmed the report, saying it is considering going private and planned to make an announcement on Tuesday, according to a company statement. Hisamitsu, known for its Salonpas pain-relief patches, joins a growing list of Japanese companies exiting the public market to shield themselves from growing regulatory and investor pressure to lift valuations and implement more oversight. Hisamitsu, which traces its origins to 1847 in the Saga prefecture in southwestern Japan, develops and sells prescription and drugstore products. Salonpas became the first-ever topical pain-relief patch approved by the US Food and Drug Administration in 2008.

Source: The Edge Markets January 06, 2026 04:33 UTC